161 related articles for article (PubMed ID: 28913325)
1. Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Hu Y; Chen X; Chen X; Zhang S; Jiang T; Chang J; Gao Y
Can J Gastroenterol Hepatol; 2017; 2017():2736547. PubMed ID: 28913325
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
Melek J; Sakuraba A
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.
Yao L; Wang H; Dong W; Liu Z; Mao H
Medicine (Baltimore); 2017 Jan; 96(3):e5861. PubMed ID: 28099343
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002010. PubMed ID: 24627308
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for osteoporosis in nonmetastatic prostate cancer patients receiving androgen-deprivation therapy: a systematic review and meta-analysis.
Ding H; Yang L; Du W; Teng Y; Fu SJ; Tao Y; Lu JZ; Wang ZP
Asian Pac J Cancer Prev; 2013; 14(5):3337-43. PubMed ID: 23803126
[TBL] [Abstract][Full Text] [Related]
7. Oral Bisphosphonate Therapy for Osteogenesis Imperfecta: A Systematic Review and Meta-Analysis of Six Randomized Placebo-Controlled Trials.
Ying ZM; Hu B; Yan SG
Orthop Surg; 2020 Aug; 12(4):1293-1303. PubMed ID: 32589343
[TBL] [Abstract][Full Text] [Related]
8. Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials.
Kasturi KS; Chennareddygari S; Mummadi RR
Transpl Int; 2010 Feb; 23(2):200-7. PubMed ID: 19793074
[TBL] [Abstract][Full Text] [Related]
9. Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy.
Lim JS; Jin SH; Kim SB; Lee JI
J Clin Gastroenterol; 2012 Sep; 46(8):669-74. PubMed ID: 22504799
[TBL] [Abstract][Full Text] [Related]
10. Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis.
Wu J; Zhang Q; Yan G; Jin X
J Orthop Surg Res; 2018 Aug; 13(1):194. PubMed ID: 30071889
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
Kan SL; Ning GZ; Chen LX; Zhou Y; Sun JC; Feng SQ
Medicine (Baltimore); 2016 Feb; 95(5):e2679. PubMed ID: 26844505
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.
Serpa Neto A; Tobias-Machado M; Esteves MA; Senra MD; Wroclawski ML; Fonseca FL; Dos Reis RB; Pompeo AC; Giglio AD
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):36-44. PubMed ID: 21894175
[TBL] [Abstract][Full Text] [Related]
15. Is there enough evidence to use bisphosphonates in HIV-infected patients? A systematic review and meta-analysis.
Pinzone MR; Moreno S; Cacopardo B; Nunnari G
AIDS Rev; 2014; 16(4):213-22. PubMed ID: 25300622
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.
Wu Y; Wang F; Zhang Z
Osteoporos Int; 2021 Jun; 32(6):1117-1127. PubMed ID: 33386876
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparisons of bisphosphonates and teriparatide in osteoporosis: a meta-analysis.
Liu CL; Lee HC; Chen CC; Cho DY
Clin Invest Med; 2017 Jun; 40(3):E146-E157. PubMed ID: 28653616
[TBL] [Abstract][Full Text] [Related]
18. Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Shi M; Chen L; Wu H; Wang Y; Wang W; Zhang Y; Yan S
BMC Musculoskelet Disord; 2018 May; 19(1):177. PubMed ID: 29848366
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials.
Mitterbauer C; Schwarz C; Haas M; Oberbauer R
Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
Chen L; Wang G; Zheng F; Zhao H; Li H
Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
